Research Article: The Safety and Efficacy of Prolonged Use of Bedaquiline for the Treatment of Patients with Pulmonary Multi-Drug Resistant/Rifampin-Resistant Tuberculosis: A Prospective, Cohort Study in China
Introduction:
The treatment of Multidrug-resistant Tuberculosis (MDR-TB) and Rifampin-resistant TB is challenging for TB control due to poor treatment outcomes, poor patient compliance, difficult management, more adverse events (AEs), high costs, and a lengthy period of treatment. In recent ten years, WHO reported that the average treatment success for MDR-TB worldwide was –%, – which was slowly improved. However, studies in different countries have reported varying treatment success rates, including a .% success rate in Sudan,…
Read more